Most foot, ankle and lower extremity surgeons have demonstrated success using off-the-shelf implants designed for generalized anatomy. However, as CT imaging, surgical planning software and 3D printed patient-matched implant creation
There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost its chance to become the first one. The drug, camlipixant,
The war between healthcare providers and payers has increasingly become a battle of algorithms, with AI tools for prior authorizations on one side and AI-powered appeals on the other. Ashis
Juno Bio, a women’s health company, announced Thursday that it has secured $3.8 million in funding, which it is using to support the opening of its first women’s health sequencing
The AMA’s latest National Physician Comparison Report shows aggregate physician burnout falling for the third straight year, down to approximately 41.9% in 2025 from 48.2% in 2023. That’s notable progress,
CMS released its proposed rule for the 2027 Medicare Physician Fee Schedule this week, which included changes to physician payment and value-based care programs, as well as major overhauls to
The Improving Seniors’ Timely Access to Care Act passed out of the House Ways and Means Committee unanimously on Wednesday, a move that many healthcare advocates are applauding. Reps. Ami
The entry story has been told. Goldman Sachs and Charlesbank hold MDVIP. Revelstoke holds a concierge platform. Frontier is building employer-facing DPC infrastructure. Marathon Health and Premise Health are scaling
Advanced cases of breast cancer now have a new FDA-approved treatment option, a Celcuity drug whose first-in-a class approach could also have applications in a wider range of solid tumors.
Digital health startups raised $7.4 billion during the first half of the year, up from $6.4 billion during the first half of 2025, according to data released this week by
